S&P 500 Futures Up In Premarket Trading; Regencell Bioscience, EchoStar Lead

Dow Jones
16 Jun

This article was automatically generated by Barrons.com using technology from Automated Insights.

With U.S. stock markets set to open in two hours, Regencell Bioscience Holdings Ltd. $(RGC)$ was up 59.0% in pre-market trading, and EchoStar Corp. $(SATS)$ was up 43.7%.

Roku Inc. Cl A $(ROKU)$, Circle Internet Group Inc. $(CRCL)$, and Incyte Corp. $(INCY)$ were all posting gains of at least 9%. In early trading, Neurocrine Biosciences Inc. $(NBIX)$ and Trade Desk Inc. Cl A (TTD) had posted declines, falling 3.5% and 2.8%, respectively.

Meanwhile S&P 500 futures were up 0.48%, with futures for the Dow Jones Industrial Average rising 0.41%. The Cboe Volatility Index futures were up 15.46%.

In commodities news, Brent crude oil futures were down 0.71%, while gold futures were down 0.36%. Bitcoin climbed 1.25% to $106,627.

The 10-Year Treasury yield rose to 4.438%.

In the previous regular trading session, the S&P 500 and the Dow were down 1.13% and 1.79%, respectively. Stocks in Asia were up overnight, with Japan's NIKKEI 225 Index up 1.26% and China's Shanghai Composite Index rising 0.35%.

In afternoon trading, stocks in Europe are up, with the STOXX Europe 600 Index climbing 0.32% and the FTSE 100 Index climbing 0.47% from the previous close.

U.S. stock markets open for trading at 9:30 a.m. ET.

Data source: Dow Jones Market Data, FactSet. Data compiled June 16, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 16, 2025 07:31 ET (11:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10